Identifying the long-term survival beneficiary of chemotherapy for stage N1c sigmoid colon cancer
Crossref DOI link: https://doi.org/10.1038/s41598-022-21331-z
Published Online: 2022-10-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Liu, Shan
Lin, Yaobin
Huang, Sihan
Xue, Shufang
Huang, Ruoyao
Chen, Lu
Wang, Chengyi
Text and Data Mining valid from 2022-10-07
Version of Record valid from 2022-10-07
Article History
Received: 26 January 2022
Accepted: 26 September 2022
First Online: 7 October 2022
Competing interests
: The authors declare no competing interests.